Literature DB >> 23308013

2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced hypertension: the beneficial effects of melatonin.

Selçuk İlhan1, Dilek Ateşşahin2, Ahmet Ateşşahin3, Emre Mutlu4, Elif Onat4, Engin Şahna4.   

Abstract

OBJECTIVE: The purpose of the present study was to evaluate the effects of melatonin on biochemical and cardiovascular changes resulting from exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a polychlorinated dibenzo-para-dioxin.
METHODS: A total of 24 Sprague-Dawley rats were divided equally into the following four groups: (1) control group was administered with 0.5 mL corn oil by gavage and 0.5 cc vehicle of melatonin (proportionally nine parts physiological serum + one part ethyl alcohol) intraperitoneally for 4 weeks, (2) the melatonin group was given 5 mg/kg/day melatonin intraperitoneally for 4 weeks, (3) the TCDD group was given 500 ng/kg/day TCDD by gavage for 4 weeks and (4) the TCDD + melatonin group was given TCDD (500 ng/kg/day) by gavage and melatonin (5 mg/kg/day) intraperitoneally simultaneously for 4 weeks. Systolic blood pressure was evaluated by the tail-cuff method. Vascular responses to phenylephrine and acetylcholine were evaluated in the isolated thoracic aortas.
RESULTS: TCDD not only augmented the systolic blood pressure but also increased the contractile responses to phenylephrine in aorta. Melatonin reversed the blood pressure augmented by TCDD and decreased the contractile responses to phenylephrine in aorta. TCDD induced an increase in the malondialdehyde levels in kidney tissue and melatonin did not change it. Therefore, TCDD caused a decrease in glutathione levels in kidney tissues and melatonin reversed it.
CONCLUSION: Present data demonstrated that TCDD may lead to an increase in blood pressure via increased renal oxidative stress and vascular reactivity. However, melatonin might ameliorate the blood pressure disturbed by TCDD in part by decreasing the oxidant activity induced by TCDD.
© The Author(s) 2012.

Entities:  

Keywords:  TCDD; blood pressure; melatonin; oxidative stress

Mesh:

Substances:

Year:  2013        PMID: 23308013     DOI: 10.1177/0748233712472521

Source DB:  PubMed          Journal:  Toxicol Ind Health        ISSN: 0748-2337            Impact factor:   2.273


  7 in total

Review 1.  Effects of melatonin on cardiovascular risk factors and metabolic syndrome: a comprehensive review.

Authors:  Mohsen Imenshahidi; Golamreza Karimi; Hossein Hosseinzadeh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-01-30       Impact factor: 3.000

2.  Body burden of persistent organic pollutants on hypertension: a meta-analysis.

Authors:  Su Hyun Park; Jung-Eun Lim; Hyesook Park; Sun Ha Jee
Journal:  Environ Sci Pollut Res Int       Date:  2016-04-07       Impact factor: 4.223

3.  Association between Blood Dioxin Level and Chronic Kidney Disease in an Endemic Area of Exposure.

Authors:  Chien-Yuan Huang; Cheng-Long Wu; Jin-Shang Wu; Jung-Wei Chang; Ya-Yun Cheng; Yau-Chang Kuo; Yi-Ching Yang; Ching-Chang Lee; How-Ran Guo
Journal:  PLoS One       Date:  2016-03-10       Impact factor: 3.240

4.  Maternal Resveratrol Therapy Protects Male Rat Offspring against Programmed Hypertension Induced by TCDD and Dexamethasone Exposures: Is It Relevant to Aryl Hydrocarbon Receptor?

Authors:  Chien-Ning Hsu; Yu-Ju Lin; Pei-Chen Lu; You-Lin Tain
Journal:  Int J Mol Sci       Date:  2018-08-20       Impact factor: 5.923

5.  Hypertension in Relation to Dioxins and Polychlorinated Biphenyls from the Anniston Community Health Survey Follow-Up.

Authors:  Marian Pavuk; Tara C Serio; Caroline Cusack; Matt Cave; Paula F Rosenbaum; Linda S Birnbaum
Journal:  Environ Health Perspect       Date:  2019-12-20       Impact factor: 9.031

Review 6.  Effects of melatonin on cardiovascular diseases: progress in the past year.

Authors:  Hang Sun; Aaron M Gusdon; Shen Qu
Journal:  Curr Opin Lipidol       Date:  2016-08       Impact factor: 4.776

7.  Melatonin attenuates thiocyanate-induced vasoconstriction in aortic rings.

Authors:  Alexander M Prusa; Christian A Plass
Journal:  Saudi Pharm J       Date:  2017-03-25       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.